Lanean...

Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study

BACKGROUND: Whether or not the use of metformin decreases the risk of gastric adenocarcinoma is unclear. METHODS: This was a population-based cohort study in 2005–2015. Associations between metformin use and gastric non-cardia and cardia adenocarcinomas were examined within two cohorts; a diabetes c...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Br J Cancer
Egile Nagusiak: Zheng, Jiaojiao, Xie, Shao-Hua, Santoni, Giola, Lagergren, Jesper
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2019
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6889304/
https://ncbi.nlm.nih.gov/pubmed/31591459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0598-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!